Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV

Silverarc Capital Management, LLC reported a 5.60% stake in Kalvista Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 13, 2026

Silverarc Capital Management, LLC reported a 5.60% stake in Kalvista Pharmaceuticals, Inc., 2,876,407 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G).

Stake
5.60%
Shares
2,876,407
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
SilverArc Capital Management, LLC5.60%2,876,407
Devesh Gandhi5.60%2,876,407

Source

View original at SEC

Related